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INTRODUCTION 
Machines providing artificial respiration for paralyzed patients are 
used extensively by the medical profession. These machines, commonly 
called respirators, provide the force necessary to move air in and out of 
the patient's lungs, permitting necessary gas exchange to occur between the 
blood and the atmosphere. 
Despite the common usage of respirators, relatively little is known 
concerning respiratory assistance in the newborn infant beyond establishing 
his first breaths. Lack of widespread success in the maintenance of as­
sisted respiration in newborn infants can be attributed in part to the lack 
of suitable equipment and technique. Few commercial respirators are avail­
able or suitable for maintaining or assisting respiration in the newborn 
infant. The infant's small size presents special problems in the design of 
the physical apparatus needed and in the method of providing a connection 
between infant and machine. Design is further complicated by large varia­
tions in the respiratory volumes and pressures required for artificial res­
piration. 
This study is an outgrowth of a previous effort to design a suitable 
device for clinical use in the treatment of the respiratory distress syn­
drome (RD3). This disease, also called hyaline membrane disease, occurs in 
newborn infants, particularly those born prematurely. Evaluation of the 
initial work indicated that a better physiologic matching of the machine 
characteristics to the infant was desirable. Minimal consideration had been 
given to optimizing the respirator's output flow contour so as to reduce its 
interaction with the patient's circulation. Optimizing the clinical appli­
cation of the respirator requires information about the expected response of 
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the distressed infant to assisted respiration. Such information is diffi­
cult to obtain experimentally. In short, clinical experience with the res­
pirator indicated the need for study of other important facets of the prob­
lem of infant respiratory assistance. 
The incidence of RDS is relatively high, with an estimated 25,000 
deaths occurring yearly in the United States (1). Various sources show 
respiratory distress to be a leading cause of death of liveborn infants, 
with RDS accounting for between 30 and 40 per cent of neonatal deaths. 
Despite great research activity into the cause and treatment of RDS, the 
death rate due to RDS has remained relatively constant over the past sev­
eral decades. 
Respiratory distress begins to appear in a newborn infant a few hours 
after birth. Respiration becomes labored, the normally soft chest wall 
retracting inward with each inspiration due to increased inspiratory ef­
fort. Cyanosis usually develops. The respiration rate increases signif­
icantly, indicating inefficient breathing resulting from a disturbance in 
the mechanical characteristics of the lung. Respiratory rates, normally 
about 40 per minute, often rise to 100 per minute or more. 
The underlying cause of respiratory distress is unknown. Often a 
smooth hyaline-like membrane covering many of the lung alveoli is seen at 
autopsy. It is known that such a membrane changes the elastic character­
istics of the lung, making it stiff and resistant to expansion in response 
to the intrathoracic pressure variations which occur during respiratory 
movements. In addition, the presence of the membrane causes an occlusion 
or atelactesis of many or most of the alveoli. A substantial increase in 
pulmonary work, as great as 400 per cent, is required to achieve essentially 
normal gas flow in and out of the lungs (2). Decreased effective alveolar 
membrane surface and adverse changes in pulmonary blood flow cause an ele­
vation in the carbon dioxide content of the blood. This in turn affects 
the acid-base balance of the blood and effects adverse biochemical changes 
in the body. 
Respiratory distress is a self-limiting disease and spontaneously dis­
appears within two to three days if the infant does not succumb to respira­
tory muscle exhaustion and induced biochemical changes. Treatment is aimed 
at keeping the infant alive during the critical phase of the disease pro­
cess. Attempts at treatment have included aerosol therapy to hasten dis­
solution of the membrane itself, as yet unsuccessful, and chemical control 
of the blood pH (3) (4). The addition of buffering agents to the blood is 
a supportive measure, since the change in pH is secondary to the actual 
cause of distress. A direct approach is respiratory assistance using a 
respirator. This latter approach seeks to substantially reduce the infant's 
respiratory work load and to increase the effective quantity of air avail­
able in the lungs for gaseous exchange with the blood. 
In 1958, Benson _et al. reported the successful management of three 
cases of RDS by employing intermittent positive pressure respiration using 
a commercially available respirator (5). Colgan et al^. report a similar 
success using respiratory support by means of manual lung inflation with an 
anesthesia respirator bag (6). Other successes have been reported. How­
ever, all have reported some technical difficulties. In all of these 
reports the procedure described was designed to reduce the respiratory work 
load performed by the infant. Delivoria-Papadopoulos and Swyer reported 
that assisted ventilation could result in complete restoration of normal 
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blood chemical levels in infants with RDS (7), Stahlman and others con­
clude that death often results from respiratory neuromuscular failure, and 
that intervention before irreversible biochemical changes occur may achieve 
survival (8), 
To produce adequate pulmonary ventilation by means of a respirator, it 
is necessary to distend both lungs and thorax to a volume sufficient to 
achieve the necessary gas exchange. This can be accomplished by means of 
intermittent negative pressure applied to the outside of the thorax as is 
done in a tank respirator (an iron lung), or by means of intermittent posi­
tive pressure applied at the nose, mouth, or through an endotracheal tube. 
In a healthy infant, normal inspiratory volumes (tidal volume) of 10 to 15 
ml of air are induced by an intrathoracic pressure change of about 5 to 10 
cm HgO. Technical considerations favor the use of intermittent positive 
pressure. The use of tank type respirators introduces problems of pis-
toning of the infant about the neck opening, difficulty in achieving an 
adequate tank seal around the infant's neck, and the difficulty of achieving 
respiratory rates of 100 per minute or more. These problems are suffi­
ciently severe so as to preclude the use of tank type respirators with new-
""born infants, particularly premature infants. 
In order to be effective in reducing the infant's respiratory work 
load, a respirator must either completely assume respiratory activity or 
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else synchronously amplify, or augment, it . Synchronous amplification is 
preferable because of two reasons. First, augmented respiration allows the 
subject to control the amount of pulmonary ventilation he receives and thus 
^One distinguishes between a respirator and a respiratory augmenter. 
The patient's thorax is completely passive when using a respirator and is 
active when using a respiratory augmenter. 
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regulate the concentration of carbon dioxide in his blood. Secondly, and 
most important in the treatment of RDS, severly distressed infants cannot 
be sufficiently overventilated to a degree that they will submit to passive 
ventilation. Benson et al. found it necessary to use curare (muscle relax­
ent) in order to diminish natural respiratory efforts to a degree that 
would permit the distressed infant to tolerate the respiratory rhythm of 
the respirator (5). On the other hand, efficient respiration occurs in the 
infant under augmented respiration when air is delivered to the lungs in 
phase with the infant's natural breathing cycle. Positive pressure applied 
to the face without regard to the timing of the infant's respiratory 
attempts tends to drive the air down the esophagus into the stomach. Both 
Donald and Stahlman have reported observations of a "protest" apnea when 
respiratory assistance was not directly controlled by the patient (9) (10). 
It is presumed that in protest apnea the epiglottis closes off the trachea, 
preventing air from entering the lungs. 
If positive pressure is applied synchronously with the infant's 
breathing effort, air takes its intended route to the lungs, providing the 
necessary pulmonary ventilation. Air delivered by positive pressure into 
the lungs expands the lungs (analogously to inflating a balloon) and pro­
vides most of the work required in respiration, provided the air flow con­
tour, or waveform, is optimum. Grossly incorrect flow patterns can produce 
the opposite effect, actually increasing the work of respiration. Con­
traction of the lungs and thorax by natural tissue elasticity suffices to 
allow expiration and no mechanical assistance is needed. 
Certain undesirable physiologic effects can occur in the patient being 
treated with a respirator or respiratory augmenter. Both thoracic and pul­
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monary circulation are embarrassed by positive pressures generated within 
the chest. If a respirator or respiratory augmenter is to be maximumally 
effective, it must be designed to minimize the circulatory disturbance. 
An intermittent positive pressure respiratory augmenter for the syn­
chronous amplification of inspiratory effort has been designed, constructed, 
and clinically evaluated. It has been devised primarily for use in the 
treatment of RDS in premature infants with its. design based on a study of 
the optimal respiratory augmentation process. The optimal process is con­
sidered to be that which requires the minimal expenditure of energy by the 
patient while producing the least circulatory disturbance and maintaining 
adequate gaseous exchange between the blood and inhaled gases. 
Optimization of the augmentation process extends beyond specification 
of machine parameters. Shunting of pulmonary blood flow around the active 
regions of the lung prevents adequate carbon dioxide evolution and oxygen 
^uptake by the blood. . To compensate for the adverse blood flow, a greater 
effective alveolar ventilation must be provided. The greater volume, how­
ever, creates a greater circulatory disturbance. Using a functional math­
ematical model of the cardiopulmonary system, predictions are obtained of 
the respiratory volume required to maintain or achieve normal levels of 
carbon dioxide in the blood. Supplementary information pertinent to the 
clinical use of an augmenter is also derived from the mathematical model. 
For example, data is obtained from the model to show the time required for 
a change in lung ventilation to be reflected in the arterial blood carbon 
dioxide level. 
This study, then, considers three major facets of respiratory augmen­
tation. The first is a consideration of the mechanical factors influencing 
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respiratory assistance. The second is the design of equipment. Analysis 
of how augmentation affects the overall gas exchange process of the cardio­
pulmonary system is third. A discussion of the clinical results achieved 
from the use of the respiratory augmenter is also included. 
8 
OPTIMIZATION 
Introduction 
Difficulty is experienced in the quantitative evaluation of the effi­
ciency of respiratory augmentation because the fragility of the subject, 
particularly the sick premature infant, limits the ability of the investi­
gator to make physiologic measurements. In addition, certain Important 
parameters of respiratory augmentation are not amenable to study by experi­
mental methods. Therefore, a theoretical study employing a model of the 
pulmonary pneumatic system is the only practical approach to the problem of 
maximizing the mechanical effectiveness of artificial respiration. 
Two different methods are commonly employed to ventilate a patient's 
lungs. The first is controlled respiration in which the patient is hyper­
ventilated to a point where the concentration of carbon dioxide in the 
blood is below the threshold of respiratory stimulation, inhibiting the 
natural respiratory drive. The patient's pulmonary system is then passive 
to externally induced gas flow. Controlled respiration is commonly used 
in the administration of gaseous anesthetics. 
The second method, augmented respiration, allows the subject to main­
tain active control of his respiration. A device external to the patient 
augments, or aids, the respiratory gas flow by providing an additional 
driving force. Augmented respiration is used in circumstances where It is 
desirable to reduce, but impossible to eliminate altogether, the patient's 
respiratory work load due to the impossibility or undesirability of extin­
guishing his respiratory drive. Infants critically ill from respiratory 
distress are most easily ventilated by this latter method. 
Controlled respiration is optimal when it provides adequate ventilation 
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of the lungs without impairing circulatory function. The amount of energy 
expended by the respirator in providing adequate gas movement is not of 
importance. Augmented respiration is optimum when it allows the patient to 
exert the least possible effort in obtaining and regulating adequate venti­
lation without impairing circulation. The added variable of the patient's 
contribution to the total respiratory effort in augmented respiration com­
plicates the analysis of this type of externally induced ventilation. 
All respirators and respiratory augmenters of the intermittent posi­
tive pressure (IPP) type employ some means of restricting the flow of air 
to the lungs. The air source may be volume limited, or its output flow 
may be restricted by means of a needle valve or other resistance to give it 
a constant flow characteristic (a needle valve limits flow by presenting a 
high resistance to a pressure source, analogous to the infinite resistance 
of an electrical constant current generator). 
Positive pressure respirators suitable for pulmonary ventilation of an 
infant are of two types. One is designed to deliver a fixed, but adjust­
able, volume of gas. The other provides an inspiratory phase which is 
terminated when a preset pressure is reached. The advantage of the pres­
sure cycled type is that no explicit knowledge of the appropriate respira­
tory volume is required. The pressure achieved and the volume delivered 
depend on the interaction of the respirator with the patient's pulmonary 
system. Too high a pressure cutoff may cause rupture of alveoli, while too 
low a pressure cutoff may prevent adequate volume delivery. The pressure 
cycled device has an advantage in that it automatically compensates for 
leaks at the patient-respirator interconnection since any air that escapes 
does not contribute to pressure buildup. The volume limited type is usually 
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piston driven to provide a preset volume, and has a pressure limiting 
device to prevent excessive pressure in the event of a block or constric­
tion in the patient's airway or lungs. The duration of the inspiratory 
phase is fixed by the flow rate. 
Commercial intermittent positive pressure respirators can be found 
that are neither constant flow or constant pressure generators. The Bennet 
respirator is an example of a hybrid instrument (11). Its output flow is 
greatest at the beginning of the inspiratory cycle and falls to zero at the 
end of the cycle. Its output is intended to coincide roughly with the 
patient's natural flow pattern. Certain other machines are time cycled. 
That is, they apply a constant pressure for a fixed time interval. Most 
respirators available commercially have a flow characteristic dictated by 
design expediency. 
Many respirators can also be used as respiratory augmenters particularly 
suited for use with older infants and adults. They are designed so that the 
flow and pressure cutoff may be varied over a wide range. However, little 
information is available concerning the optimum settings for various pul­
monary disorders. These devices are primarily intended to improve unequal 
ventilation by increasing the depth of inspiration and slowing the respira­
tory rate. They do not directly relieve the patient's respiratory work 
load, but rather increase the depth of respiration to promote a more effec­
tive respiratory pattern. 
Little information is available in the literature describing optimiza­
tion of augmented respiration. Several reports deal with controlled res­
piration and the characteristics of respirators designed to provide this 
type of artificial respiration. Mushin £t al_. analyze the ventilation to 
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be expected from the constant flow, pressure cutoff type respirator by 
using a simplified pulmonary analog consisting of a series RC network (11). 
They also consider the type of respirator which provides a constant pres­
sure- for a fixed time interval. Both methods, of course, assume a passive 
respiratory system. The resulting analyses are strongly dependent upon 
the parameters of the particular patient. Whittenburger describes a 
linearized mathematical treatment of the operation of several types of 
respirators and derives an equation for the pulmonary ventilation to be 
expected from each (12), 
Intermittent positive pressure ventilation is not without adverse 
physiological effects. Most important is its effect upon the circulation 
of blood within the thorax. Since the heart and great vessels are con­
tained in the thorax, they are subject to the same pressures as the lungs. 
Normal respiration generates a slight negative pressure which aids venous 
return and cardiac filling. Intermittent positive pressure ventilation 
produces a positive pressure in the thorax which, according to Maloney and 
Whittenburger, causes a slight decrease in cardiac output, an increase in 
peripheral vascular resistance, and an increase of blood volume in the 
peripheral circulation (13). Avery points out that these effects can be 
deleterious in the event of shock, or any other condition which interferes 
with peripheral circulatory adjustments (1). "In the newborn infant with 
peripheral vascular instability, and in the distressed infant in shock, 
circulatory embarrassment may be lethal when positive pressure breathing 
is instituted." Pulmonary blood pressure is normally low. Therefore, lit­
tle excess positive pressure is required to collapse alveolar capillaries, 
thus shunting blood away from areas of possible gas exchange. Critical 
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closing pressures are as small as 5 or 6 mm Hg. 
Adverse circulatory effects of positive pressure respiration can be 
minimized if the mean applied pressure is low. Cournand £t al, report that 
in normal adults if expiration occupied at least 50 per cent of the respir­
atory cycle and if expiratory mask pressures were close to atmospheric 
pressure, there were no significant adverse circulatory effects (14). A 
mean pressure at the face mask of 7 to 10 mm Hg caused cardiac output to 
fall about 15 per cent. Mushin _et al. argue for a minimal mean intrapul-
monary pressure by saying that it is unlikely that important additional 
gaseous exchange occurs once the alveoli have expanded during inspiration 
( 1 1 ) .  
The increase of functional dead space is another important physio­
logical effect of positive pressure respiratory assistance^. The increase 
is proportional to the peak pressure and independent of the time course of 
pressure buildup (15) (16). The elastic nature of the airway and the 
cheeks permits expansion under pressure, increasing their contribution to 
the total dead space in the patient-respirator system. This necessitates a 
greater volume of air per breath than in unaided inspiration. Respiratory 
dead space is normally large in distressed infants, the ratio space 
^tidal volume equaling 0,5 to 0.6. Watson found an increase in this 
ratio (normally 0.2) of 50 per cent when the peak inspiratory pressure was 
doubled in" paralyzed adults (15). When negative pressures were applied 
during the expiratory phase to assist expiration, this ratio also doubled, 
presumably because of the collapse of some alveoli and their subsequent 
iDead space is that part of the inhaled volume that does not partici­
pate in gaseous exchange. In a respirator, it is that excess volume that 
does not flow into the infant. 
13 
failure to reopen during the next breath. No similar numerical data is 
available for newborn infants. 
It is generally agreed that all devices aiding respiration should be 
limited with respect to the maximum pressure that they can deliver. A 
greater maximum "safe" pressure allows a proportional increase in the 
volume of air that can be introduced into the lungs. A dilemma occurs in 
treating very sick infants; those who need respiratory assistance the most 
have the least compliant lungs, necessitating delivery pressures higher 
than can be sustained without danger of rupture. Excised lungs of infants 
usually tolerate 35 cm HgO positive pressure without rupturing, according to 
Gribetz (17). Avery reports sustaining 50 cm HgO across excised lungs with­
out rupture (18). It should be noted that the pressures referred to here 
are intrapulmonary pressures and not the pressures normally produced at the 
face. 
The Pulmonary Analog 
Anatomically, the lung is a system of millions of air passages and 
capillaries contained in an elastic tissue substance. In the human the 
several subdivisions or lobes are connected together by air passages, the 
bronchial system, whose air passages combine together to form a common 
duct, or trachea, to the atmosphere. The lungs share the thoracic cavity 
with the heart and great blood vessels and are held firmly to the parietal 
pleural (or wall) surfaces by surface tension. The lungs can be most 
simply thought of as a balloon or bellows suspended in the thoracic cavity 
and held in a state of partial inflation by a negative pressure between the 
balloon and the thorax. Its natural elasticity limits the expansion in the 
resting state. 
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A change in thoracic volume produces a corresponding change in the 
volume of air in the lungs. Contraction of the diaphragm and the external 
intercostal muscles enlarges the thoracic and lung volumes, while their 
relaxation and the elasticity of the chest wall and lungs serve to decrease 
the lung volume. 
Figure 1 shows a simple mechanical analog of the thorax and lung com­
partments, The thorax is represented by a "concertina" type bellows. Sus­
pended inside is another bellows, the inside of which communicates with the 
atmosphere through the airway. The compliance of the relaxed thorax and 
lung bellows (defined as A V/AP = C, with A V and A P representing changes 
in volume and pressure respectively) are noted as and Cj respectively. 
A constriction in the airway represents laminar and turbulant flow resis­
tance to moving air and is designated R^. represents the mass of a 
cylindrical volume whose length is that of the effective length of the air­
way, is associated with the inertial forces produced by air flow into 
and out of the lungs, 
F represents the effective muscle force applied to the thorax compart­
ment during inspiration. Force F is directed in the opposite direction in 
the event of an active expiration (normally expiration is passive). The 
muscle system providing this force is a complex combination of agonist and 
antagonist (action and reaction) muscles acting through a lever system 
defying description. Both the muscles providng inspiratory effort and those 
providing expiratory effort are in some degree of contraction throughout the 
respiratory cycle. 
An electrical analog of the pulmonary system is shown in Figure 2 
together with the appropriate values for the analog elements. The electrical 
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analog model is useful in this study because pulmonary parameters are 
evaluated as lumped components and are therefore easily described as elec­
trical analogs. All components are assumed to be linear. Deviations from 
linearity axe relatively minor and are discussed below. The assumption of 
linearity allows the use of the principle of superposition in a mathemati­
cal analysis. Certain elements of the analog, such as viscous effects of 
the thorax tissue, which produces second order effects, are omitted to 
keep the model as simple as practical while still preserving its usefulness 
in describing the functional properties of the lung and thorax. Additional 
components fuch as the naso-pharyngeal region compliance are included in 
this model in addition to those shown in Figure 1. Figure 3 shows a varia­
tion of the basic analog in which the differences in the values of com­
pliance and airway resistance between different lobes are included. The 
differences are inconspicuous in a healthy lung, but in an atelectic lung 
the variation from lobe to lobe can be appreciable. This effect leads to 
differences in the time constant of filling (R^C^) so that a short inspira­
tory interval leads to unequal filling of the lobes and a short expiratory 
interval causes unequal emptying. Time constant variations between lobes 
can be as great as 200 per cent. 
Data for the evaluation of the analog parameters were obtained by 
measuring 6 healthy (0 to 3 days old) and 3 distressed newborn infants (one 
was preterminal). Some of the parameters have been previously reported in 
the literature, but those reported were obtained during spontaneous respira­
tion, rather than when respiration was augmented (19). Lung compliance, 
C^, and airway resistance, R^, were measured by the method of Cook £t al. 
(20). A water filled plastic feeding tube was inserted into the esophagus 
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and the pressures were measured. These readings were considered to 
accurately represent Intrathoracic pressures. Air flow was measured simul­
taneously by means of a pneumotachograph. The flow record was manually 
integrated at selected points to provide simultaneous volume measurement. 
Pressure in excess of that needed to fill a linear lung volume was attri­
buted to the airway resistance, R^, pressure drop. Viscous resistance of 
the lung tissue is necessarily included into by this method. C^, the 
compliance of the alveolar air is computed from the ideal gas law, PV = 
constant. 
^ ^ = 1000 = 1.0 ml per cm H„0 oer liter (2-1) 
a A P 990 2 ' 
Cj., the thorax compliance, cannot be measured during spontaneous res­
piration because the contribution of the respiratory muscles to the total 
pleural pressure, P^^, cannot be directly determined. is defined as 
C = ^ ^thorax _ ^''^t (2-2) 
t p p 
thorax A pi no flow 
where 
= tidal volume 
Ppl flow pressure difference between beginning and end of 
inspiration 
In fact, Cj. has no meaning except when the state of the thorax muscle tone 
is specified. These muscles, the diaphragm and intercostals, are normally 
in a state of partial contraction in their role of controlling posture (21). 
Attempts have been made at evaluating by having subjects voluntarily 
relax. These measurements, of course, conflict with others taken in totally 
paralyzed subjects. 
To be useful in the evaluation of assisted respiration, the value of 
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Cj. should be determined during active respiration. then represents the 
elasticity of the chest muscles, with their normal degree of tone, and asso­
ciated connective tissue. In the mechanical analog may be thought of as 
the elasticity of a spring in series with the force F, which pulls on the 
bellows representing the chest. is not the elasticity of the bellows 
itself. The assumption is made that the muscle source is of low impedance, 
that is to say, external forces can do little to influence its pattern of 
output. C^, as shown in the electrical analog, is the total internal 
impedance of the muscle source. 
is estimated in the active infant by noting the change in the pres­
sure, created by inspiratory volume which is generated by a constant 
flow augmenter connected to the infant. Values of typically found are 
in the range of 4 to 5 ml per cm HgO pressure. As a check on this method, 
can be evaluated by an alternate procedure. C^, the lung compliance, is 
estimated as described above during spontaneous breathing. Lung compliance 
is not affected by muscle tone and is assumed constant. Then 
V. 
= insp (2-3) 
^mpeak "^insp/Cl 
where 
Vinsp = volume of air delivered by augmenter 
^mpeak ~ pressure at mouth during augmenter respiration 
At the end of inspiration, flow ceases and the pressure drop across Rg, 
the airway resistance, disappears. The end point pressure corresponds to 
peak pressure. The values obtained by both methods are in close agreement. 
Data published on the measurement of Cj. in apneic, paralyzed infants 5 to 
75 days of age is considerably higher, as might be expected (22). 
J 
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Lg, the analog of the air mass being accelerated in the airway, is 
estimated to be equivalent to a mass of air 10 cm long and 0.6 cm^ cross 
section. The equivalent of the air mass converted to appropriate units is 
0.013 cm HgO per liter per sec^. L^, the thorax mass equivalent, is neg­
ligible in comparison to the elasticity of the thorax and is ignored in 
subsequent use of the analog model (23), Since the infant and respirator 
must be considered as an integrated system, Lhose properties of the respi­
rator known to be'invariant with respect to design are included in the 
model. The compliance of the tubing connecting the augmenter to the infant 
together with the air contained therein, termed C^, is 0.4 ml per cm HgO, 
assuming a total tubing length of 10 feet of \ inch inside diameter Tygon 
tubing. 
Figure 4A shows the exponential shape of during spontaneous res­
piration, Although Ppj, is generated by the muscle source and subsequently 
modified by the action of C^, the muscle source itself is assumed to have 
an exponential output waveshape. This assumption deviates slightly from 
the actual situation but creates only a small error in the analysis. Figure 
4B shows the same subject's pressure in the upper airway immediately after 
the airway is sealed from the atmosphere. It represents approximately the 
pressure created directly by the muscle source. This action is analogous 
in an electrical circuit to disconnecting the load to obtain the equivalent 
voltage source of a Thevenin equivalent circuit. The analog model to be 
used subsequently will contain a perfect voltage generator to represent the 
respiratory muscle activity. 
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Optimization Criteria 
Specifically, a respiratory augmenter should expand the chest and 
lungs of a patient in such a way as to minimize the patient's respiratory 
muscle work with minimum circulatory embarrassment. The ideal augmenter 
should thus: 
1. Produce a positive pleural pressure, throughout the inspira­
tory phase. 
2. Create minimum resistance to expiratory air flow. 
3. Produce a minimum mean pressure in the lungs, Pj, and thorax, 
Ppj, during the inspiratory phase. 
4. Produce an air flow sufficient to stimulate adaptation, but 
small enough to minimize facial mask pressure. 
The first requirement assures that the augmenter will always aid the 
patient's respiratory effort. Positive pressure in the pleural cavity 
indicates that the augmenter output is working against the musculature. 
Negative pr'essure indicates that the infant is trying to inspire against 
the action of the respirator; with a limited flow device this attempt is 
futile. 
Minimum resistance to expiratory flow assures that the patient is 
doing the least work necessary for expiration. The energy required to 
expire passively is stored in the elastic tissues during inspiration. In 
addition, minimal expiratory resistance promotes quick emptying of the 
lungs, permitting lower mean intrathoracic pressure. Since the lungs and 
thorax are effectively in series with respect to air flow, the conditions 
of minimal Pj and P^j are simultaneously satisfied. An analogous situa­
tion is that of two capacitors in series in an electrical circuit. The 
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voltage across one is always proportional to the voltage across the other. 
Experimental observations of infants and laboratory animals indicate 
the occurrence of adaptation to the inspiratory force of the respiratory 
augmenter. Presumably the adaptation is mediated through the Hering-Brewer 
reflex^. Initially, augmentation does not affect the subject's inspiratory 
effort, as evidenced by the intrathoracic pressure shown in Figure 5A, The 
augmenter, a constant flow device in this case, is delivering slightly more 
than normal tidal volume. Note that the augmenter output is superimposed 
upon the normal exponential waveform. Figure 5B shows a change in Ppj 
when the augmenter is delivering twice the normal tidal volume. Notice the 
reduction in the negative amplitude, indicating the animal's adaptation to 
the device, i.e., the reduction of his respiratory effort. Hyperventilation 
is not the cause of the reduction in the respiratory effort in this case. 
In Figure 5C, is shown to be normal immediately after the augmenter is 
disconnected. Carbon dioxide concentrations in the blood cannot change 
instantaneously to effect such a change in respiratory effort. Simultaneous 
measurements of blood pCOg before, during, and after augmentation as shown 
in Figures 5A, B, and C indicate no significant change. 
Figure 6 also documents the adaptation effect in an experimental ani­
mal. Notice a significant reduction in inspiratory duration when the tidal 
volume is increased to 24 ml, twice the normal tidal volume for this animal. 
\. 
(The ripple artifact present in many of the P^^ tracings is due to heart 
beat changing the volume of the thoracic cavity.) Cross et al. document 
the adaptation effect in newborn infants by noting that a threshold of 
^The Hering-Brewer reflex causes slowing of inspiration or apnea upon 
forced inflation of the chest. 
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forced inspiratory volume exists, above which a transient apnea occurs (24). 
They state the transient apnea is particularly pronounced immediately after 
birth, decreasing somewhat with age. Clinical observations of newborn 
infants, made as a part of this study, indicate a rapid adaptation to an 
augmenter. A mildly distressed infant's respiratory pattern will change 
from labored inspiration to one compatible with relaxed sleep. On the basis 
of the observations discussed, the assumption is made that twice normal 
tidal volume is sufficient to induce adaptation. 
Once the infant has sufficiently adapted, optimum agumentation is that 
which produces adequate ventilation while minimizing circulatory disturb­
ance. In very sick infants the blood PCO2 is so elevated and the respira­
tory drive so intense that adaptation is slight regardless of the volume 
inspired. As respiratory distress becomes more severe and then recedes 
the infant goes through a period of non-adaptation of varying intensity. 
Thus, the augmenter characteristics must be the best compromise for both 
conditions. 
Air flow must be great enough to prevent a negative but low 
enough to prevent development of excessive pressure at the mask. Increasing 
flow increases the pressure drop across the airway resistance. Flow ceases 
to be laminar at a velocity of about 150 ml per sec, assuming a uniform 
cylindrical airway of 0.6 cm diameter. High mask pressure increases leak­
age from around the mask and also forces air down the esophagus, distending 
the stomach and small intestine. 
Non-linearity 
Linearity is assumed for each of the components in the respiratory 
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analog. Pressure-volume curves of both the lungs and thorax are found to 
be "3" shaped in adults. It was therefore deemed necessary to investigate 
the linearity of these compliant components in infants to assure that the 
assumption of linearity was valid. 
Figure 7 shows the pressure-volume relationship for the lungs and 
thorax for two sick infants as well as for two healthy ones. Note that the 
diseased lungs show a more linear relationship than the healthy ones. 
Figure 8 indicates the degree of non-linearity of total compliance (lungs 
and thorax combined) as a function of the rate of filling. Unequal time 
constants of two or more lung subunits can produce the time dependent non-
linearity. Presumably this effect is small enough to be ignored since it 
is of smaller magnitude than subject to subject variations. 
Data for Figures 7 and 8 were obtained while the subject was being 
ventilated by a constant flow augmenter. The augmenter volume output was 
varied to produce data on various degrees of filling. The difference be­
tween the nasal pressures observed at the beginning and conclusion of 
inspiratory flow was considered to be the actual change of pressure occur­
ring across the series combination of the lungs and thorax. This method 
adds air compression and upper airway compliance to the value of compliance 
encountered. Upper airway compliance cannot be measured directly in the 
uncooperative subject. Measurement of the upper airway compliance in an 
adult showed that the compliance is linear within the limitation of a 
rather large possible experimental error^. 
^The cooperating subject closed off his trachea by straining as during 
defecation. Simultaneous pressure and volume measurements were made using 
a stiff face mask connected to the subject. 
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Airway resistance is inherently non-linear because of two effects. 
First, as air velocity increases, laminar flow turns to turbulent flow. 
The pressure drop across a resistance is proportional to the second power 
of flow when flow is turbulent. Secondly, the airway is compliant, 
expanding, as flow increases, tending to counteract the first effect. 
Fortunately, does not enter directly into the analysis of devices 
delivering flow from a limited flow source. is sufficiently linear to 
permit its use as a constant in the analysis of a constant flow pressure 
source. 
Optimization 
An augmenter can be designed to produce any of an infinite variety 
of possible inspiratory flow waveforms. In the analysis to follow five 
waveforms, each representing a distinct type of output, will be considered. 
Each type represents the output possible from a particular design philos­
ophy, The five flow waveforms are; 
1. Constant flow 
2. Exponential flow (decaying exponential) 
3. Ramp flow (increasing with time) 
4. Sine waveform flow 
5. Reverse ramp flow (decreasing with time) 
Most other waveforms can be considered to be simple deviations of the five 
considered. 
A series circuit consisting of R^, Cj, and has a response, in terms 
of the voltages across Cj and C^, equivalent to that of the analog model 
shown in Figure 3. The deviations in response between the two remain 
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within a few per cent, as verified experimentally. Therefore, in the fol­
lowing analysis the simple series circuit analog will be used. 
Consider first the case of the respiratory muscles being inactive, as 
in apnea or adaptation to the augmenter. The mean pressure across C^, 
analogous to the average voltage across in the electrical circuit, is 
given by 
T.rt 
P - I I f(t)dt dt (2-4) 
mean ^ 
t / T  
where 
Tg, the inspiratory duration is defined by 
pTo 
"'•J. 
f(t)dt, the tidal volume 
'o 
and 
f(t) - air flow, in ml per sec 
From Figure 9 it can be seen intuitively that P is a minimum when 
' mean 
f(t) = at^, when n approaches infinity. The flow, f(t), is then an impulse 
function. This function is not physically realizable and so need not be 
considered further. Computing the mean pressure during inspiration as a 
function of Vj., for a given T^, for the five types of flow considered, one 
obtains the following; 
1, When f(t) is a constant flow, f(t) - a, 
r^ o rc T 
Wn - j J a dt dt . , (2-5) 
and 
= po adt = a T^ (2-6) 
Jo 
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so 
P =» ^ (2-7) 
mean 
2. Iflien f(t) is a ramp, f(t) = at, 
•To Pt T 2 
p  3  1  P f a t d t d t o S O j  ( 2 - 8 )  
w jo A ^
and 
\ "f 
wo 
To . Ï.2 
™I atdt = ^ (2-9) 
so 
T> = .33 ^t (2-10) 
mean pr——-
^t 
3. t'Jhen f(t) is exponential, stemming from a constant pressure 
Pq applied to the face, f(t) = (P^/R^e "t/RgC ^ 
-T. rt 
'ta.. 
Pmean ' ' ^  ^ <" 
V (ï„ - RgC (1 - e -To/Ka^ )| . (2-11) 
C.T t o 
and 
rT 
V =f ° ^0 e dt = P^C (1 - e -To/RgC) 
^ Jq R 
(2-12) 
so 
P = ^t - VtRgC (2-13) 
C, (1 - e -To/RaC) 
In this case R^, the airway resistance, and C, the total compliance 
(CtCi/C^+Cj), influence the mean pressure by determining the filling time. 
Assuming typical values of R^ = 0.03, C = 2,0, and = 0.5, 
26. 
V 
P = _i2—Ë_ approximately (2-14) 
mean 
The lower bound of P = .5 V^/C occurs when RC aoproaches infinity, the 
mean t t 
exponential degenerating into a ramp. 
4. When f(t) is a sine waveform, f(t) = a (1 - cos -SL- t), 
^o 
^ a: 
I "I a (1 - cos ^  t) dt dt 
Î ^ i 
_ a o 2 a o 
2 Ct ff2 
and 
5. I'Then f(t) is a reverse ramp, f(t) = a (1 - t/T^), 
»T. rt 
I'I. 
~ f ° a (I - t/Tg) dt = 
J o 
(2-15) 
T_, 
a (1 - cos JL. t) dt = a T (2-16) 
T O 
0 ^0 
SO 
P = .31 ^t (2-17) 
mean 
, , a (1 - t/T ) dt dt = a "o (2-18) 
mean C,T^ / ° 3 
0 ^ 0  
and 
T T 
V = I n _ f/T 1 (2-19) 
so 
Van - (2-20) 
^t 
Figure 10 shows the volumes produced by the five types of flows as a 
function of time, -niean proportional to the area under each curve, 
since pleural pressure is equal to the increase in thoracic volume divided 
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by at any instant of time. Subject to the constraint of minimal cir­
culatory disturbance, a constant pressure device producing an exponential 
flow is shown to be the poorest and a device producing a sine waveform flow 
the best. These results can be extrapolated to show that a parabolic shaped 
flow pattern is slightly better than ramp flow, etc. 
Next, consider the situation where the respiratory muscles are active, 
that is, adaptation has not occurred. It is assumed that the pulmonary 
system is linear, and further, that the muscles could be represented as a 
perfect pressure source. Regardless of the volume forced into the thoracic 
cavity, the pressure waveshape and amplitude remain constant. Only because 
of these assumptions, the principle of superposition is valid. ^pi> then, 
is the algebraic sum of the pressure produced across by the respiratory 
augmenter and that produced by the respiratory muscles. 
Mean pressures computed for no respiratory muscle activity also apply 
when the muscles are active. Spontaneous inspiratory attempts always pro­
duce negative pressures in the thorax. Then, because the principle of 
superposition is valid, 
P,(active) = P (inactive) - P .(muscle source) (2-21) 
pi pi pi 
or 
T 
P , (active) = P (inactive) - 1 / ° P .(muse) dt" (2-22) 
pi mean pi mean t" / ^ 
o J  o 
where 
r P^J(muse) dt = a constant, the mean P^^ from muscle activity. 
Thus choosing a f(t) based on no respiratory muscle activity is also valid 
for the situation where the respiratory muscles are active. 
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A positive pressure P^j in the thorax during inspiration is con­
tributing to the inspiratory act by providing some or all of the energy 
necessary to inspire. In addition, the positive pressure stimulates the 
pulmonary stretch receptors to inhibit further inspiratory activity for that 
particular breath. Figure 10 shows a comparison of net pleural pressures 
expected from each of the five flow waveforms. To facilitate comparison, 
each flow waveform is of the correct amplitude to produce a final pressure 
of P^j • 2Vj./C^ for an inspiratory duration of T^. The shaded areas show 
the duration of negative pressure for each flow waveform. During the 
periods of negative pressure the patient is working against the action of 
the augmenter. P generated by each of the flow waveforms can be expressed 
pi 
as, 
P i(t) " r f(t)dt - P (t)spontaneous (2-23) 
pi Jo pi 
The pressure created by the action of the respiratory muscles, 
P , is represented by the equation 2-24. 
pi spontaneous 
P , =-P (1 - e -at) (2-24) 
pi o 
Pg and a are experimentally determined parameters. Examination of P^^ 
recordings produced during spontaneous inspiration in six subjects (two 
with respiratory distress) shows that P^^ terminates at about 90 per cent 
(+ 5 per cent, - 8 per cent) of its ultimate value if a simple exponential 
curve fit is assumed. This appears to be true in newborn infants irrespec­
tive of the range of encountered. Thus a representative model of P^^ is 
a simple exponential curve with duration of two time constants (87 per cent 
of ultimate value). 
Figure 11 shows graphically how the curves of P^^ shown in Figure 10 
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are obtained. This particular representation is for constant flow. Note 
that regions of negative pressure occur when the flow rate is too high or 
too low. In order to deliver two tidal volumes in the normal inspiratory 
interval T^, the optimal flow rate for constant flow waveshape can be 
derived as follows: 
subject's maximal flow • initial flow (spontaneous respiration) 
f(t) = bj e -t/b2 (2-25) 
and 
Vt = b^bg (1 - e "t/b2) (2-26) 
where bj and bg are parameters of the pulmonary system 
subject breathes in two time constants, or T^ = 2b2 
then 
^initial = 
optimum augmenter flow = subject's initial flow 
a - 2.3 Vt (2-28) 
To 
where a = augmenter flow, in ml per sec 
average TQ for sick infants = .35 sec and V,. = 12 ml 
therefore 
a = 78 ml per sec for distressed infants 
average Tq for healthy infants - 0.6 sec and = 15 ml 
therefore 
a = 57 ml per sec for healthy infants 
These values form the lower limits for the augmenter flow output because of 
the assumption that the augmenter inspiratory interval, T^, is equal to the 
infant's inspiratory interval. For the conditions assumed above the infant 
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would receive 2.3 Vj. rather than the 2.0 assumed necessary. In the case 
of the reverse ramp and exponential flows, the initial flow is always 
greater than that demanded by the infant. 
Constant flow and reverse ramp flow waveforms are acceptable on the 
basis of the mean pressures that they produce as well as their initial flow 
rates. Ramp flow and sine waveform flow have insufficient initial flow 
rates. The exponential flow waveform has an ideal initial flow rate but 
produces excessive mean pressure. Constant flow is therefore the best 
choice because of its low mean pressure generation. In addition, it has 
the advantage in that the initial flow is one-half that of the reverse 
ramp and thus the airway pressure drop is less than one-half that caused 
by the reverse ramp flow (turbulent flow pressure drop is proportional to 
flow ). This means lower face mask pressures and consequently less air is 
lost to leakage and to abdominal distention. It is therefore concluded 
that an optimal augmenter output characteristic should be constant flow of 
approximately 75 ml per sec. 
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AUGMENTER 
Cook ^  al. in a recent review of current treatment of respiratory 
distress say that "...only some form of assisted respiration can aid in 
carbon dioxide removal by actually increasing the alveolar ventilation and 
supplementing the infant's own strenuous respiratory efforts. Practical 
devices, whether the positive pressure or tank type, are needed to treat 
this disease. It is apparent at present that a successful device depends 
upon interested and highly skilled personnel. The apparatus seems too 
necessarily complex to allow general use. If a device, however complicated, 
is marketed, those fetuses with the greatest chance of developing respira­
tory distress may be recognized before delivery and cared for in appropriate 
centers" (19). One objective of this study was the development of a prac­
tical respiratory augmenter which would be successful from a treatment 
standpoint and at the same time be simple enough to be used by medical per­
sonnel not highly skilled in the use of respiratory augmenters. 
Previous attempts at developing a satisfactory device to synchronously 
augment respiration have enjoyed only limited success. Donald devised a 
machine which utilized the infant's inspiratory efforts to trigger an input 
of air from a high pressure source through a reduction valve (25). Techni­
cal difficulties included the mask, which by description must have had too 
much dead space, insufficient positive pressure, and lack of a volume lim­
iting control. His results did indicate temporary benefit. Melville and 
Hodder developed an augmenter using negative pressure external to the 
chest, a tank type machine, to expand the chest and thus move air into the 
lungs (26). The enclosure surrounding the body was necessarily large and 
air movements into and out of the enclosure were slow, especially with 
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respect to the breathing rate of premature infants. Again, dead space was 
not controlled. These and other attempts to develop an infant respirator 
were not satisfactory because of poor speed and phase response, together 
with too much dead space in the air passages^. 
V» 
Design Requirements 
A respiratory augmenter must provide the following functions to be suc­
cessful: 
1. Accurately sense the beginning of the inspiratory cycle, 
2. Meter and deliver a predetermined volume of air or gas mixture 
to the subject, preferably at a constant flow of 75 ml per sec. 
3. Provide a satisfactory machine-patient connection which can be 
left in place for periods of 48 to 72 hours. 
4. Provide adequate supervisory control so that an alarm is given 
if the infant becomes apneic. 
5. Provide controlled respiration in the event of failure of natural 
inspiratory attempts. 
Inspiratory effort can be sensed by any of several possible methods. 
These include negative intranasal air pressure, diaphragm movements, and 
electromyographic skin potentials. The simplest method appears to be nasal 
pressure detection since special devices need not be attached directly to 
the infant. Donald, and Melville and Hodder have shown this method to be 
practical (25) "(26). 
Inspiration must be sensed within a few milliseconds after its begin­
ning in order that the augmenter deliver gas in phase with inspiration. 
'•The Emerson Infant Respirator, a patient cycled tank type device is 
available in the United States. There have been no reports of its effec­
tiveness. 
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Inherent delays in the mechanical linkages of the augmenter dictate detec­
tion as soon as possible. This is accomplished by detecting a negative 
pressure at the nose. If inspiration is to be sensed within 10 milli­
seconds of initiation, a differential pressure (with respect to the atmos­
phere) threshold of less than 2 mm HgO must be determined using a sensitive 
pressure transducer. Sensitivity of this magnitude requires that the 
pneumatic circuitry be noncompliant to prevent attenuation of the already 
small negative pressure signal at the device. 
Metering of air can be accomplished by means of a piston driven to 
deliver a predetermined volume. Volumes of 10 to 40 ml of air or a gas 
mixture delivered at a respiratory frequency of up to 120 breaths per min­
ute are required. The augmenteras output pressure must be limited to a 
maximum of 40 cm H2O to prevent damage to the lung. The approximate maxi­
mum pressure normally encountered is: 
p = ^ = (2.3)(12) = 14 cm H^O (3-1) 
max r 2 2 
^total ^ 
The ability to precisely control the oxygen percentage in the inhaled 
gas is important. In cases where oxygenation of the patient appears ade­
quate, current medical practice limits the oxygen concentration to 40 per 
cent to prevent retrolental fibroplasia (vascular growths in the eye). 
In the event the subject is not adequately oxygenated, as determined by 
blood gas measurement, higher concentrations may be used. Water vapor is 
usually added to the inspired gas to prevent excessive fluid loss through 
respiration. 
Since positive pressure breathing is feasible for use on infants, the 
problem of how to apply pressure to the upper airway becomes an important 
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one. Previously, face masks have been unsatisfactory for extended use 
because of the difficulty of constructing them with little dead space, as 
well as the difficulty of obtaining a tight seal to the face. Masks suit­
able for infant use, according to Avery, have at least 5 cc of dead space, 
almost one-half of the infant's normal tidal volume (1). Endotracheal 
tubes and tracheotomy connections can be used if considerable caution is 
observed. They are, however, quite inconvenient and because they bypass the 
subject's nasal area, where humidification normally occurs, the augmenter 
output must be saturated with water vapor. 
Constant attention by highly trained medical personnel may be imprac­
tical in cases where a device such as this would be used in a small com­
munity hospital. Therefore, the device should be failsafe, giving notice 
to attending personnel of failure of either machine or infant. It should 
initiate controlled respiration if the infant becomes apneic. A period of 
forced ventilation will often be sufficient to stimulate the infant to 
resume breathing. (Forced ventilation substitutes for tactile stimula­
tion, such as turning the infant or slapping its feet to promote the re­
sumption of regular respiration.) A common respiratory pattern in pre­
mature infants is one of periodic breathing, appearing as brief periods of 
apnea of 5 to 10 seconds duration in a sequence of breaths. It is common 
enough to be considered normal in these infants. Thus an alarm and forced 
cycling system must have an inherent delay of approximately 15 seconds to 
prevent false indication of failure. 
In summary the augmenter should have the following properties; 
1. 'Sense inspiration within .10 milliseconds by detecting negative 
pressure at the nose. 
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2. Have a face mask and pneumatic system with essentially no dead 
space. 
3. Capable of delivering by intermittent positive pressure 10 to 
40 ml of gas mixture at a constant flow rate of 75 ml per 
second and a repetitive rate of 120 per minute. 
4. Capable of detecting the cessation of patient inspiratory 
attempts for a period of 15 seconds or greater, then providing 
a preset forced rate of respiration, while indicating cessation 
by a suitable alarm able to detect return of inspiratory attempts, 
5. Be failsafe in operation as well as simple to operate by personnel 
not highly skilled in its operation. 
System Description 
For descriptive purposes, the augmenter can be organized into two 
major systems; one, the electrical system, and the other, the mechanical-
pneumatic system. The electrical system provides the control function 
while the mechanical system performs the actual respiratory assistance. 
Figure 12 shows the complete respiratory augmenter. 
The mechanical system provides the sensing, metering, and delivery 
functions of the respirator. Included are the differential pressure trans­
ducer, the metering compressor, the valve, and the face mask with its asso­
ciated connecting tubing. This system is shown in block diagram form in 
Figure 13. Note the two independent air paths, one for inspiration and 
the other for expiration. Separate paths prevent mixing and eliminate 
dead space. The valve controls the on-off cycle of each path. Normally, 
when not actuated, the valve is in the position shown. 
An operating cycle starts when a negative pressure (with respect to 
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the atmosphere) is developed in the face mask by the infant's inspiratory 
attempt. A rubber one-way valve (Serria Valve) prevents outside air from 
entering through the exhaust port during this phase. The transducer is 
actuated by the pressure differential, which in turn triggers the elec­
tronic system. Immediately the electronic system actuates the metering com­
pressor and valve. 
The valve rotates in such a way as to close the exhaust path and the 
gas inlet to the compressor as well as exposing the delivery path to the 
compressor. Air is then forced into the lungs under pressure generated by 
the travel of the compressor piston. At the completion of the gas deliv­
ery, the valve closes the delivery path and opens the exhaust path. Elas­
tic contraction of the subject's thorax and lungs forces the respired air 
out. Positive pressure relative to the atmosphere opens the one-way valve, 
allowing the respired air to be exhausted to the atmosphere. A path is also 
opened by the valve action from the air or air-oxygen supply to the com­
pressor, allowing the compressor to be recharged. The breathing cycle is 
ended and the device is again ready to detect the infant's next inspiratory 
effort. 
The electrical, or electronic, system provides the sensing and timing 
functions for the compressor. It also provides supervisory and control 
functions as well as supplying power for the mechanical components. Figure 
14 illustrates the organization of the component blocks. Design for the 
most part is based on switching type circuitry. All timing functions in 
the electronic system occur as a result of a pulse being received. 
An output from the nasal pressure transducer, in the form of a pulse 
(whose wave shape approximates the pressure at the nose), is amplified and 
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coupled to a Schmitt Trigger stage. The trigger circuit detects the point 
at which the nasal pressure has exceeded a certain threshold. An output 
from the Schmitt Trigger actuates the forward bistable switch, which in turn 
actuates the forward clutch in the mechanical system. Completion of the 
metering action reverses the forward bistable switch state, deactivating 
its associated clutch and actuating the reverse bistable switch. This in 
turn actuates the reverse clutch, returning the Valve and metering compres­
sor piston to their initial positions. The reverse bistable switch is then 
reset to its initial state. 
Supervisory equipment includes a respiration rate meter and a rate 
detector-alarm, which alerts attending personnel should natural respiration 
cease. An automatic timing sequence determines if the infant's failure to 
inspire is temporary. If the infant's respiratory rate drops below 50 per 
cent of the value preset by a front panel control, the timer circuit is 
actuated. Rates from 30 to 120 breaths per second are selectable. . If at 
the completion of a 15 second interval, the rate has not returned to 60 per 
cent of its initial value, the augmenter begins ventilating the infant at a 
preset rate, the same rate that the detector circuit is set for. After 10 
seconds, the augmenter again pauses 15 seconds to ascertain if the infant 
has begun respiration of its own accord. If at any time during the 10 sec­
ond forced rate interval the infant regains 60 per cent of his former rate, 
the augmenter immediately switches back to the normal assisted respiration 
mode. An audible tone alarm sounds whenever the time circuit is active. 
The augmenter is capable of the following operational modes: 
1. Normal; assisted respiration, patient controlled. 
2. Test; one cycle for each operation of the test switch. 
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3, Automatic; normal mode with detection of breathing failure and 
subsequent forced respiration. 
4. Manual; adjustable rate forced breathing. 
These modes are selected by means of front panel switches. Provision is 
made for connecting the rate meter to either the forward bistable switch, 
to read augmenter rste, or the Schmitt Trigger circuit, to read patient 
rate, if the two should differ. (This occurs during automatic mode opera­
tion when the infant has become apneic.) The alarm is failsafe so that if 
for any reason the augmenter is prevented from cycling, the alarm will 
sound. The tone generator providing the alarm is energized by a small 
rechargeable battery. 
Test, or single cycle, operation is achieved by simulating a trans­
ducer output pulse at the input to the transducer amplifier. Single cycle 
operation is desirable when initially determining respiratory volume and as 
a method for priming the breathing circuit when an oxygen enriched mixture 
is used. 
Details of Operation 
Figure 15 shows the construction of the pneumatic system and identi­
fies its various parts. Output volume is determined by the length of the 
piston stroke in the metering compressor. Rotational motion from a small 
induction motor is coupled to a rack and pinion gear through two clutches^. 
Activation of the forward clutch, by the forward bistable switch, causes 
the rack gear to push the piston inward, forcing out the desired volume at 
a constant rate. In a similar manner, the reverse clutch returns the piston 
^Vibrac Corporation, Model MPC 11, Magnetic Particle Clutch. 
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to its original position. A tight piston seal is maintained by a diaphragm 
between piston and cylinder^. Piston stroke is limited on forward travel 
by a forward limit switch and on reverse travel by a reverse limit switch. 
The letter's position is adjustable by means of a front panel control, pro­
viding a method of varying the piston displacement from 0 to 40 ml. The 
forward and reverse limit switches reset the forward and reverse bistable 
switches respectively, disconnecting current to the appropriate magnetic 
clutch. 
Initial rotation of the forward clutch output shaft rotates only the 
valve core. After a fraction of a revolution of the clutch shaft, the 
valve core has been rotated the necessary 90° and a friction clutch inter­
posed between the two allows the forward clutch to rotate further without 
advancing the valve core. An angular lost motion coupling from the forward 
clutch to the rack prevents the piston from moving until sufficient time 
has elapsed (25 milliseconds) for the valve to be properly positioned. A 
solenoid latch prevents inadvertent movement of the valve core while 
adjusting the piston displacement. Decreasing the volume setting when the 
piston is idle would move the piston inward, advancing the valve core, if 
the latch was nonexistent. The latch solenoid is energized during the 
initial part of the forward cycle to permit free motion of the valve core. 
The valve core is repositioned to its original position upon completion of 
the piston's forward motion. Again the lost motion coupling prevents pis­
ton return until the valve core has returned to its initial position. 
Nasal pressure is converted into an electrical signal by a Statham PM 
I 
Bellofram rolling rubber diaphragm. 
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97 strain gauge low pressure transducer (working range 0 to .05 psi). The 
strain gauge elements are connected in a bridge configuration. To eliminate 
stability problems inherent in a DC amplifier, the bridge output is ampli­
fied by a low frequency AC amplifier with a bandpass of 5 to 500 cps. 
Three stages of amplification are needed to produce a signal increase in 
excess of 1000. The amplified output is coupled to a Schmitt Trigger cir­
cuit which determines when a certain pressure threshold has been exceeded. 
A sensitivity control on the front panel adjusts the trigger threshold. 
An Qutput from the Schmitt Trigger is connected to the forward bista­
ble switch through two AND gates. The first gate is controlled by the 
automatic mode timer. l^Jhen an output from it and the trigger are coinci­
dent, an output is generated which is coupled to the second gate. If the 
reverse bistable is not energized, the output pulse from the first gate is 
allowed to pass through the second gate and trigger the forward bistable. 
An inhibiting function is necessary during the piston reset cycle to pre­
vent pneumatic transients, arising from valve action, from prematurely 
actuating the forward bistable switch. An additional gate circuit connects 
the manual rate oscillator to the forward bistable switch in the absence of 
an output from the automatic mode timer. This connection allows the bista­
ble switch to be driven by an oscillator at a rate controlled from a front 
panel control. Another gating circuit prevents both forward and reverse 
bistable switches from being operative coincidentally, which might result 
when the augmenter is initially turned on. 
A second output from the Schmitt Trigger goes to a rate meter and rate 
detector. A monostable multivibrator, acting as a current source, charges 
a parallel RC circuit. The voltage across the capacitor is proportional to 
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the "on" time of the multivibrator, which in turn is proportional to the 
number of pulses received from the trigger. The capacitor voltage operates 
a front panel rate meter and also a relay connected through a DC amplifier. 
Contacts on the relay activate the automatic mode timer when insufficient 
voltage appears across the capacitor, providing the necessary detection of 
insufficient respiratory rate. Temperature compensation is provided in 
this circuit to insure stability under adverse ambient temperatures. 
Power is provided by a regulated voltage supply to operate the clutches 
and electronics. Three voltages are used, -12 volts for the pressure trans­
ducer, -27 volts for the electronics, and -40 volts for the clutches. The 
clutches are rated at 28 volts, but are purposely overvoltaged to reduce 
engagement time to 3 to 4 milliseconds. 
Transistor circuitry is used throughout and is mounted on three plug-
in phenolic cards to simplify maintenance and modification. The entire 
unit weighs less than 25 lbs, has dimensions of approximately 6 x 13 x 16 
inches, and is easily portable. The complete unit is shown in Figure 12. 
Clinical Operation 
As stated above, some sort of connection must be provided between 
machine and patient. A close fitting nasal mask of an acrylic shell, with 
a dead space of less than one half ml, has been developed for use with this 
augmenter (27). The shell is filled with a soft plastic material which 
remains permanently compliant, and is then fitted by pressing it to the 
infant's nose for a few seconds and allowed to set^. It is then sealed to 
the infant's nose with surgical (colostomy bag) cement. Newborn infants 
lAny soft dental lining material may be used. Bosworth "Tru-Soft" 
dental lining is excellent for this purpose. 
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are mandatory nasal breathers. This fact eliminates the need for a con­
nection to the mouth, leaving it accessible in case of vomiting, etc. The 
entire operation of preparing a mask takes less than 10 minutes. 
Gases to be inspired are mixed and humidified in a vented plastic con­
tainer external to the augmenter. Precise control of the oxygen concentra­
tion is obtained by using a calibrated venturi valve between the high pres­
sure oxygen supply and the mixing chamber. A shallow water level is main­
tained in the chamber to assist in humidification since oxygen from the 
hospital central source is dry. It is not necessary to humidify the gas 
mixture to saturation since the inhaled gases pass through the nares and 
nasopharynx where additional humidification is accomplished. 
An occasional deep breath, or sigh, is helpful in preventing additional 
atelactasis (alveoli closure), which tends to occur with fixed tidal vol­
umes, Although no special device is incorporated in the augmenter to per­
mit sighing, breaths of twice normal respirator output can be obtained by 
a simple manual maneuver. The exhaust one-way valve is covered with the 
palm of the hand, preventing expiration. An additional inspiratory gasp 
usually occurs, known as Head's paradoxical reflex (24), Since the pres­
sure transducer is AC coupled, it will respond, triggering the augmenter. 
The augmenter delivers a second volume of air adding to the first remaining 
in the patient. The hand is then removed from the exhaust port, and the 
infant exhales. If the infant fails to respond for a second breath, the 
augmenter is manually triggered using the test pushbutton. 
Operationally, the augmenter performance is within the specifications 
outlined for its design. It has been tested on several rabbits, whose 
respiratory system closely approximates that of a newborn infant, and used 
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clinically in the treatment of more than a dozen sick premature infants. 
Some problems of reliability, particularly with respect to clutch life, 
have been encountered but have been apparently overcome by the use of a bet­
ter clutch^. 
IVibrac Corporation, Magnetic Particle Clutch, MPC 11-C-l. 
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CLINICAL APPLICATION STUDY 
The use of augmented respiration for the treatment of distressed in­
fants requires knowledge of the expected performance of the infant's re­
spiratory system. For example, it is desirable to know the alveolar venti­
lation required to achieve a certain reduction in the carbon dioxide con­
centration in the blood. It is also useful to know at what rate the 
reduction process occurs. Clinically useful information such as this is not 
easily obtained experimentally. Experimental isolation of a single variable 
of the respiratory process of a healthy laboratory animal is in itself dif­
ficult, Adding the complication of a fragile, sick infant whose respira- . 
tion is being mechanically augmented makes the task exceedingly difficult. 
A theoretical analysis of the respiratory process can yield clinically 
useful information. A mathematical model can be formulated incorporating 
the variables which have clinical significance. Solutions to the model 
equations provide reasonably accurate predictions of the respiratory sys­
tem's response to augmentation. Since many of the biological processes 
relating to respiration are incompletely understood, any theoretical analy­
sis must necessarily be at best an approximation. Even so, an approxima­
tion can be most valuable when experimentally derived information is una­
vailable. 
A mathematical model for the carbon dioxide elimination and oxygen 
uptake processes of a hypothetical 2,5 kg newborn infant is devised and 
analyzed in this study of the clinically important aspects of respiratory 
augmentation. It is used to predict the effect of pulmonary blood shunts 
found in distressed infants. In healthy infants, essentially all of the 
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venous blood perfuses active alveoli on its way to the arterial circula­
tion. All of the blood therefore participates in gas exchange with air in 
the lung alveoli. In distressed infants, much of the venous blood either 
bypasses the lungs entirely in its flow to the arterial circulation, or it 
perfuses nonfunctional alveoli. Shunted blood sidesteps the carbon dioxide 
removal and oxygen absorption processes in the lungs, leading to elevated 
carbon dioxide and depressed oxygen tensions. The effect of increased 
alveolar ventilation produced by respiratory augmentation in reducing 
arterial pCOg in the presence of pulmonary shunting is examined by use of 
the model. 
The model is also used to examine the function of the respiratory con­
trol system in the presence of shunting. Carbon dioxide homeostasis is 
normally maintained by this control system. Results of the analysis help 
to answer the question of the ability of the newborn infant's respiratory 
control system to adequately maintain arterial pC02 when connected to a 
patient cycled respiratory augmenter. 
Using a model of the pneumatic components of the pulmonary system, an 
analysis is made of the pulmonary pressure waveforms to be encountered in 
augmented respiration. Various tidal volumes and the air flow rates at 
which they are delivered are studied. The results provide a catalog of sig­
nificant pressure waveforms, providing information for clinically optimizing 
the above variables. 
Carbon Dioxide Elimination Model 
Innumerable investigators have confirmed that blood pCO is the 
c • 
dominant factor controlling pulmonary ventilation. Oxygen tension and pH 
of the arterial blood, together with voluntary effort, exert a strong 
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influence on the rate and depth of respiration only when the blood pCOg is 
at or below its normal value. (In newborn infants the normal arterial 
PCO2 ranges from 30 to 35 mm Hg.) At higher levels of pCO^ carbon dioxide 
is the predominant factor in respiratory control. • An increase in arterial 
PCO2 causes a proportional increase in lung ventilation, which in turn 
causes the arterial pCOg to fall. This mechanism maintains homeostasis of 
the blood pC02 to within a few per cent of its nominal value in spite of 
widely varying metabolic activity. From an engineering point of view the 
mechanism functions as a closed loop proportional control system. 
Several studies of the cardiopulmonary system considered as a feedback 
controlled system appear in the literature. Grodins £t £l, produced the 
first theoretical model of the carbon dioxide "respiratory chemostat" (28), 
Their model included three compartments; the lungs, the tissues, and the 
error sensing controller linked to venous pC02. The model predicted sur­
prisingly well the transients in alveolar ventilation created by the inha­
lation of carbon dioxide. Morgan and Lange expanded the basic model to 
include circulation transit time between the lungs and chemoceptors located 
in the midbrain (29). Their model was intended to show that periodic, or 
Cheyne-Stokes, respiration could be caused by abnormal transit times^. 
This would create a phase lag in the control system, causing the system to 
become unstable. Others have added refinements such as an additional com­
partment representing brain tissue and associating the chemoceptor with car­
bon dioxide tension in that compartment. 
Chilton and Stacy developed a mathematical model of the lung compart-
^"Periodic" refers to variations in the amount of air breathed per 
minute, not respiratory rate. 
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ment which more accurately describes the carbon dioxide evolution as a 
function of time (30). Two years' later they published a parallel model 
describing the oxygen absorption process occurring in the lung (31). These 
two models present a more precise description of the lung processes than 
used in the control model studies. 
Carbon dioxide tension in the arterial blood is perhaps the best 
index of the adequacy of the pulmonary system function in the clinical sit­
uation. Thus the model to be described is conceived so that arterial PCO2 
or its equivalent, the arterial carbon dioxide concentration, becomes the 
unknown variable. The assumption is then required that metabolic output, 
cardiac output, and the like are known parameters. 
Four principal functional units comprise the respiratory system and 
its controller. They are the following; 
1. Lungs and associated blood vessels (CO2 elimination), 
2. Body tissues (COg storage). 
3. Circulatory system (CO2 transport). 
4. Chemoceptor and associated neural components (COg control). 
The interconnection of these components is shown in schematic form in Figure 
16.  
Functional mathematical descriptions are obtained by writing con­
tinuity equations for each of the first three compartments. A continuity 
equation equates the amount of carbon dioxide Initially present in the com­
partment with the amount which is added and the amount which is removed. 
It can be written more precisely with time as a variable as shown in equa­
tion 4-1. (4-1) 
Vol d Concentration = rate of CO, delivered - rate of C0« removed 
d t 
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A fourth equation is written to describe the chemoceptor-brain-respiratory 
muscle link. It is an experimentally derived description of the sensitivity 
of the controller in terms of its input, arterial pCO^, and its output, 
lung ventilation per minute (commonly called Vg, or minute volume). 
Several assumptions must be made to allow simplification of the model 
to a reasonable degree of complexity. Second and third order effects are 
generally ignored. Where the biological process is not completely under­
stood, an intelligent guess must be made as to what actually occurs. As­
sumption validity is tested by comparing the model's predicted behavior 
with that observed clinically. Simplifying assumptions for the purposes of 
this study are as follows; 
1. Cardiac and metabolic outputs are constant, 
2. Details of the cardiac and respiratory cycles are ignored for 
the examination of slowly varying transient phenomena. 
3. Tissue and venous blood COg tensions are equal. 
4. Dissociation curves (relating tension to concentration) are 
linear and equal for arterial and venous blood. 
5. Dissociation curve slope of blood and tissue are equal. 
Beginning with the lung, the continuity equations are written as fol­
lows : 
dfPalv \ 
V760-47I = - V, ( Palv \+ Q(x _ X,) (1 - k) (4-2) 
dt 1760-47] ^ 1 
where 
= lung volume (functional residual capacity) in liters 
= effective alveolar ventilation in liters per minute 
Q = cardiac output in liters per minute 
49 
k = fraction of shunted blood 
Palv *^*^2 tension in alveolar gas in mm Hg 
Palv concentration in alveolar gas 
760-47 
Xy =» concentration of CO g in mixed venous blood 
= concentration of COg in arterial blood leaving the lung 
The denominator of the term describing alveolar gas concentration, 760-47, 
represents the barometric pressure minus the partial pressure of water 
vapor at body temperature, 37°C, The effective fraction of cardiac output 
participating in gaseous exchange is represented by Q(1 - k). Arterial 
blood pGOg is assumed equal to alveolar gas pCOg. Even with a pathologic 
membrane separating the capillaries from alveolar spaces, most authorities 
consider carbon dioxide to be so diffusible that any barrier severe enough 
to impede carbon dioxide diffusion would be such an overwhelming barrier 
to oxygen diffusion as to be incompatible with life (32). 
In order to eliminate the details of diffusion, lung volume varying 
with inspiration and expiration, non-ventilation of alveoli, and the like, 
the parameter of effective alveolar ventilation is used. Effective 
alveolar ventilation, V^, is that volume of air needed to produce the same 
gas exchange in a real lung as in the constant volume idealized lung com­
partment. Since it is impossible to quantitate all the known physiologic 
mechanisms involved in respiration, the use of effective alveolar ventila­
tion is the only logical way of assuring model accuracy. can be deter­
mined clinically by use of the following relationship; 
V COj evolved per minute (4-3) 
A av. CO2 concentration 
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To equate alveolar gas pC02 with arterial blood pCO^ the relationship 
between the tension of carbon dioxide physically dissolved in the blood and 
the total concentration of carbon dioxide in the blood must be knotm. 
Approximately 95 per cent of the total carbon dioxide in the blood is held 
in chemical combination. Figure 17 shows the relationship between pCOg and 
the concentration fraction in neonatal blood (33). Note the difference in 
carbon dioxide carrying capacity between oxygenated blood (pOg = 90) and 
reduced blood (pO^ = 40). Oxygen and carbon dioxide concentrations simul­
taneously change in the lungs and tissues, giving rise to a "physiological" 
dissociation curve, shown in Figure 17 as the dotted line. It is this dis­
sociation curve which provides the relationship between pCOg and concentra­
tion used in the model. As stated above, it is assumed that the relation­
ship is linear. The dissociation curve zero intercept decreases as pC02 
increases, (.075 for p^COg = 60 mm Hg vs. ,10 for p^CC^ = 40 mm Hg) while 
the slope remains constant (dX/dpC02 = .0067). When high p^COg levels are 
anticipated in computations, Xo, the zero intercept, is assigned a value of 
.075, whereas when low values of p^COg are anticipated, Xo = .10 is used. 
For differences of p^COg - p^COg greater than 6 mm hg, dX/dpCOg decreases 
while Xo increases. The error arising from the assumption of a constant 
slope is discussed below. 
Combining the following equations 
PaC02 = PACO2 (4-4) 
X = .0067pC02 + Xo (4-5) 
with 4-2 gives 
dt 
dXL 
- Xo) + - k) (Xv - Xl) (4-6) 
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where 
Xo - dissociation curve zero-intercept 
p^C02 = alveolar gas tensions 
Similarly the carbon dioxide continuity equation for the tissue com­
partment is given as 4-7. 
Vj = equivalent tissue volume in liters 
p^ = tissue gas tension 
M = CO2 evolved from tissue metabolism in liters per' minute 
All soft tissue, excluding the blood, is included into one equivalent 
volume V^, for the storage of COg. Carbon dioxide derived from metabolism 
is held in physical solution in the tissues and released to the venous 
blood by diffusion. Thus venous blood and tissue carbon dioxide tensions 
are equal. The dissociation relationship for tissue is assumed equal to 
that of blood. Blood plasma has essentially the same linearized dissocia­
tion curve as whole blood, and extracellular fluids are similar to plasma. 
No direct experimental data pertaining to tissue carbon dioxide dissocia­
tion is available for man. 
Equating p^COg and p^CO^ together with the dissociation relationship 
V d (PT/760-47) 
dt 
. M + qcXg - x^) (4-7) 
where 
gives 
d X. 
V M 
dt .21 V, (4-8) 
Continuity in the circulatory system is represented by the following 
equation; i 
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Q Xg . Q k K^ , + Q(1 . k)XL 
or 
Xg = kXy + (1 - k)Xj. (4-9) 
where 
k = effective fraction of cardiac output bypassing the lungs 
Normal newborn infants may shunt as much as 25 per cent of their cardiac 
output from the venous to the arterial side of the circulation in the first 
few days following birth. Severely distressed infants may shunt as much as 
70 per cent (32). 
The final equation, representing the controller, is determined experi­
mentally, It relates arterial carbon dioxide tension to respiratory minute 
volume. The respiratory chemoceptor is thought to be located in the mid­
brain, Thus it responds to brain tissue pC02 rather than arterial or 
venous tensions directly. Because tissue pCG^ is sensed, a time delay is 
produced between the appearance of a change in arterial pCOg and a resulting 
change in ventilation. Information about phase delay between changes in 
pCOg and Vg is very incomplete, limiting the usefulness of any respiratory 
system model to accurately predict fast transient behavior. 
The relationship between ventilation, expressed in terms of Vg, and 
alveolar carbon dioxide tension, as measured by Avery et al., is used in 
this model (34). As stated above, alveolar and arterial carbon dioxide 
tensions are considered to be equal. Because of this equality, the data of 
Avery et £l. for the 2.5 kg newborn infant can be represented by the fol­
lowing equation: 
2.5 Vg = 0.12 pgCOg - 3.3 (4-10) 
Equation 4-10 can be written in terms of concentration. 
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Vg . 18 X . 5.1 (4-11) 
Only a fraction of inspired gas participates in gaseous exchange in the 
alveolij due to respiratory dead space and excessive ventilation of certain 
alveoli. Converting equation 4-11 into an expression in terms of alveolar 
ventilation by adding a fractional multiplier to account for the dead space 
gives,JtJi.e following; 
#6 - d (18Xg - 5.1) (4-12) 
where 
d = dimensionless parameter, the fraction of effective minute volume 
The parameter d varies from 0.0 to 0.8 depending upon conditions in the 
lung. 
Summarizing, the carbon dioxide elimination function of the respiratory 
system can be represented by the following equations: 
dXy V 
-dt -gA- «-«> 
L L 
dX 
Xg « kX^ + (1 - k)X^ (4-9) 
= d (ISXg - 5.1) (4-12) 
Oxygen,Uptake Model 
The arterial blood oxygen tension depends on the amount of alveolar 
ventilation, diffusing capacity of the lung, blood perfusion and distribu­
tion of inspired gas within the lung, and venous to arterial circulatory 
shunts. A study by Nelson et al. showed that circulatory shunts and dis-
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tribution of inspired air into inactive alveoli are the principal causes 
of low oxygen tension in the blood of distressed newborn infants (35). 
Diffusion of oxygen into the alveolar capillary blood is not significantly 
impaired in distressed infants, according to their study. 
Because of severe circulatory shunting in the distressed infant, 
high concentrations of oxygen in the inspired air are required to insure 
adequate oxygen saturation of the arterial blood. All capillary blood 
perfusing active alveoli will be saturated (all red cell hemoglobin 
chemically combined with oxygen) by the normal concentration of oxygen in 
room air. When this blood mixes with blood that bypassed the oxygenation 
process, the resulting admixture has a lower degree of oxygen saturation. 
If, however, additional oxygen is added to the blood perfusing the active 
alveoli by forcing it into physical solution, then the overall arterial 
oxygen concentration is increased. 
A simple mathematical model describing oxygen transfer across the 
lungs is developed and analyzed here to predict the inspired oxygen con­
centration required to produce a given oxygen concentration in the arterial 
blood. The nomenclature for this model is the same as that used for the 
carbon dioxide model, with the understanding that the symbols denoting con­
centrations refer to oxygen unless otherwise noted. 
The model is developed by writing an expression for the oxygen con­
tinuity in the lungs. Since the quantity of oxygen entering the lungs 
must equal that leaving under steady state conditions, the following ex­
pression applies; 
'A " Q » " W W-U) 
The arterial-venous oxygen concentration difference, Xg - X^, has been 
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experimentally observed to be 0.04 volume-fraction in distressed infants 
by Strang and MacLeish (36). Using the same equation form as for tissue 
carbon dioxide, equation 4-8, the steady state continuity equation for oxy­
gen dissolved in the tissues is written as follows: 
Q(Xa - V = JL_ (4-14) 
RQ 
where 
RQ = respiratory quotient, i.e., CO2 vol. evolved 
Og vol. uptake 
Assuming that Q = 0.30 liters per minute, li = 0.012 liters per minute, and 
RQ = 0.8, the calculated a-v difference is 
X„ - X„ = .012 = .05 (4-15) 
(.3)(.8) 
The value computed is that commonly accepted for healthy adults. The 
value experimentally observed by Strang and MacLeish will be used, how­
ever, in the computations to follow in an effort to obtain greater accu­
racy. 
Substituting = 0.04 into equation 4-13 gives 
V. = Q(1 - k)(,04) = (.3)(.04)(1 - k) - ,057 (1 - k) liters per 
Xatmos -2' 
minute (4-16) 
the minimal alveolar ventilation required to produce saturation of the 
blood perfusing active alveoli. is observed to be greater than 0.1 to 
0.2 liters per minute in distressed infants according to Nelson et al. 
(35). Thus spontaneous respiration is assumed to produce sufficient al­
veolar ventilation to permit full saturation of the available blood. The 
oxygen concentration of the blood leaving the active lung compartment,' 
is given by equation 4-17. 
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= .20 + (Xg^^g - .21)(673)(.00003) (4-17) 
The oxygen concentration of the normal atmosphere produces a concentration 
X^ of 0.20. If the inspired gas concentration is higher than the normal 
21 per cent, additional oxygen enters the blood in physical solution. The 
second term of equation 4-17 describes the contribution of the physically 
dissolved oxygen to X^. The partial pressure in mm Hg of oxygen in excess 
of that produced by the 21 per cent normal oxygen concentration is 
(X^tnjos " .21) (673) (atmospheric pressure minus water vapor tension minus 
carbon dioxide tension equals 673 mm Hg). Physically dissolved oxygen 
concentrations increase at the rate of 0.000031 volume-fraction per mm Hg 
increase in partial pressure. Combining equation 4-9, which describes 
circulatory shunting, with equation 4-17^produces equation 4-18. 
X = «20 + .02 (1 - k)(%atmos " «21) - .24 k (4-18) 
a 1 - k 
This equation describes the value of arterial oxygen concentration to be 
expected from a given value of inspired oxygen concentration. 
Analysis 
Infants suffering from respiratory distress show a marked increase, 
in blood carbon dioxide tension. The basic cause for this increase is 
uncertain. It may result from central nervous system depression, loss of 
pulmonary gas interchange effectiveness, or both. Use of augmented res­
piration is based on the assumption of central nervous system adequacy. 
Thus it is desirable to determine what effect pulmonary system inefficiency 
has on p^COg. 
Respiratory regulation of p^COg is effected through proportional con­
trol (37). -Deviations from the. desired value of p^COg produce proportionate 
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increases in the output of the system's mechanism for correction. If the 
lung, as the correcting apparatus, is insufficiently sensitive to the 
error signal produced by the brain, the steady state error of the con­
trolled system will become large. A primary characteristic of a propor­
tional control system is its inherent error. The steady state error is 
inversely proportional to the system's overall sensitivity. Loss of sen­
sitivity can result from pulmonary shunting and increased pulmonary dead 
space. Thus the central nervous system, acting as the system controller, 
may be functioning perfectly, yet the controlled variable, the p^COg, may 
appear to be abnormally high. 
Figure 13 shows the steady" state p^COg of the hypothetical newborn 
infant whose respiratory parameters are given in Table No. 1. The data for 
Figure 18 was obtained by solving equation 4-19 for various values of k 
and d, 
.21d (18Xa - 5.1) + Q(1 - k) ) ( + 
.021d (18*8 - 5.1) 
.21d (18Xg - 5.1} + 1(1 - k) (4-19) 
Equation 4-19 is the result of combining equations 4-6, 4-8, 4-9, and 4T12. 
The derivatives with respect to time found in these equations are set equal 
to zero to obtain the steady state value of X^. An increase in cardiac 
output, Q, shifts the curve representing a specific value of k downward, 
while an increase in metabolic output, M, shifts the curve upward. Al­
though values for M and Q applicable to a specific infant must be introduced 
into the calculation of X^, the data of Figure 18 should be reasonably 
representative of most newborns weighing about 2.5 kg. An infant with a 
high metabolic output will usually compensate by increasing cardiac output. 
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Variations in the arterial-venous carbon dioxide concentration difference, 
M/Q, between infants are miner, the value always being close to 0.04 during 
spontaneous respiration. 
Typical values of d, the effective ventilation fraction, vary from 
0.6 to 0.8 in healthy newborn infants, while k is approximately 0.2. 
Values of d range from 0.2 to 0.5 and k may be as high as 0.7 in distressed 
infants, according to the data of Nelson et £l. (32). .The typical path of 
the disease process, from a study by Strang and MacLeish, is shown in 
Figure 18 (36). Note that it is possible for the PaC02 to increase as much 
as 20 to 30 mm Hg due solely to increased shunting and dead space. It is 
shown, then, that the increase in carbon dioxide tension can result from 
the normal error produced by the respiratory control system. Thus it can 
be concluded that during moderate distress the infant's respiratory con­
trol system is probably functioning and will prevent hyperventilation if 
the efficiency of the effector mechanism, the lung, is increased by re­
spiratory augmentation. 
In the case of severe respiratory distress no such conclusion can be 
drawn, since clinical experience shows that minute ventilation, Vg, is 
significantly less than equation 4-12 would predict. No evidence has been 
presented to indicate whether the malfunction in severe distress is neural 
depression, respiratory muscle failure, or both. If respiratory muscle 
work is reduced by augmentation, Vg should increase if the malfunction is 
caused wholly or in part by muscle fatigue. 
Both pulmonary shunting and alveolar ventilation determine how much 
excess carbon dioxide can be removed from storage in the body fluids. 
Figure 19 shows the efficiency of the pulmonary system in exhausting car-
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bon dioxide as a function of shunting and alveolar ventilation. A greater 
efficiency implies a greater overall respiratory system sensitivity. 
Since the use of a respiratory augmenter increases alveolar ventilation in 
the distressed infant, Figure 19 shows its potential effectiveness. Effi­
ciency for the sake of this discussion is defined in the following way; 
Efficiency (per cent) = Pv^Q2 " ^ iqo (4-20) 
P/O2 
Normally, spontaneous ventilation produces a venous-arterial difference of 
approximately 6 mm Hg tension. An increase in alveolar ventilation in­
creases the efficiency of gas exchange. This in turn tends to increase the 
venous-arterial difference, allowing more carbon dioxide stored in the tis­
sues to be picked up by the blood and eventually exhausted. 
For computation of the data shown in Figure 19 a steady state is as­
sumed, That is, PyCO^ and M remain constant. Although actually invalid, 
the assumption allows one to study the effect of changes in k and on the 
potential ability of the infant to exhaust excess carbon dioxide. Analyt­
ically, the carbon dioxide content of arterial blood under these circum­
stances is given by 
Q(1 : k)^  \ + .016 VA (4-21) 
V ,21 + (1 - k)Q J ^ ,21 + Q(1 - k) 
Equation 4-21 is the result of combining equations 4-6 and 4-9. is con­
verted to PgCOg using the dissociation curve shown in Figure 20, is 
assumed to remain at 0,475, corresponding to a p^COg of 60 mm Hg, and car­
diac output, Q, is assumed to be 0,30. The linear physiologic dissociation 
curve is used in the calculations for Figure 19, Errors in p^COg resulting 
from the use of the physiologic dissociation curve should be less than 5 
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per cent, with the maximum error occurring at the conditions of = 1.0 
and k = 0.0, 
Inspection of Figure 19 indicates that with sufficient alveolar ven­
tilation all values of shunting up to about k •= 0.7 permit an ultimate 
decrease in PgCOg. Shunting in excess of k = 0.7 does not permit the main­
tenance of the necessary venous-arterial difference of M/Q, The corre­
sponding minimal efficiency required is shown by the horizontal dotted line 
in Figure 19. When shunting exceeds a value of k = 0.7, no amount of ven­
tilation will suffice. The data of Nelson et al. and Strang and MacLeish 
showed no infants surviving when venous admixture, or shunting, exceeded 
k = 0.7 (32) (36). Only a moderate increase in alveolar ventilation in 
excess of that occurring in spontaneous respiration is necessary in main­
taining pCOg equilibrium for values of shunting up to k = 0.6. However, 
alveolar ventilation must be increased considerably to effect significant 
reductions of p^COg. It is important to note that Figure 19 represents 
potential respiratory system ability and not the ultimate value of p^^Og 
to be expected. 
Increasing the infant's alveolar ventilation will decrease his p CO . 
a 2 
The reduction occurs rather slowly, the PaC02 changing exponentially with 
time. The ultimate values reached for various values of alveolar venti­
lation are shown in Figure 21, while the time required to reach 63 per 
cent of the ultimate value is shown in Figure 22. Sixty three per cent of 
the ultimate change occurs after a time equal to that of the infant's 
cardiopulmonary time constant. At a time equal to two time constants 87 
per cent of the ultimate change has occurred. The time constant arises 
from the solution of the first order differential equation describing 
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carbon dioxide storage. 
From a consideration of the equation of continuity for the lungs, 
equation 4-6, it is apparent that the lung has its own time constant. This 
time constant is negligible compared to that of the complete cardiopul­
monary system. The time constant ^  of a first order differential equation 
is equal to _1 when it is written in standard form. 
oc 
d 
iL +_1,Xt = K (4-22) 
dt 
Therefore, obtaining 'VL from equation 4-6, 
'Vl = • 
Q(1 - k) - A (4.23) 
'21 VL Vl 
For the typical values of 0 = 0.3 and = 0.045, together with the 
maximum expected value of k = 0.6 and the minimum expected = 0.2, the 
time constant Vt = 2.5 seconds approximately. Since the time constant of 
the entire cardiopulmonary system,Hfp , is expected to be greater than 3 
minutes, the gas exchange process in the lung compartment can be assumed to 
be a steady state process, thus eliminating a first order differential equa­
tion from consideration. That the above assumption is valid has been veri­
fied by solving the carbon dioxide elimination model equations simultaneous­
ly using an analog computer. Solutions including the lung compartment as a 
dynamic process do not noticeably differ from the analytical solution below. 
Combining the steady state version of the lung equation 4-6, together 
with 4-8 and 4-9, one obtains 
+ Q /l - fk + l] X = (4-24) 
'21 ( I .21 + Q(1 - k)7 
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/ .016 VA \ 
( .21 Va + Q(1 - k)  
Solving 4-24 yields 
Xv • Xvss (>Vo - " (ifHV * ir) 
where 
= —, M , + M + . 10 the steady state solution 
Q(1 - k) .21 (1 - k) 
(4-25a) 
= initial venous concentration, i.e., the steady state value of 
at the arbitrary time t = 0 
If all other respiratory parameters remain constant, a change in V^, induced 
by an increased tidal volume from the augmenter will lower the venous carbon 
dioxide concentration 63 per cent of the difference between the initial and 
ultimate concentrations in the time 
I j p  = + Vt 
Q(1 - k) • 
The value of X^ to which the process will ultimately proceed in an infinite 
amount of time is given by X^^^, the steady state solution to the equation 
4-24. After an infinite period of time 
X, . K M/0 + .10 ^  4.76 M (4.26) 
1 - !< Va 
Equation 4-26 is obtained from 4-25a by combining it with the identity 
*3 + = *V (4-27) 
Figure 21 is based on a value of M/Q = ,04. 
Large values of V^, which cause X^ - X^ to be greater than 0.04, 
change the physiological COg dissociation curve slope. This change in 
slope can cause a maximum error of approximately 0.6 minutes in the time 
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constants shown in Figure 22. The error is not present in the computation 
of ultimate values, since during steady state conditions the dif­
ference- will approach 0.04, or a corresponding tension difference of 5 mm 
Hg. 
By referring to Figure 21 it can be seen that safe levels of carbon 
dioxide tension can be reached with moderate values of alveolar ventilation 
except when pulmonary shunting reaches a value of K = 0.6 or greater. A 
ratio of V^/M = 50 corresponds to an alveolar ventilation of 0.6 liters per 
minute. The theoretical minimums of p CO for the case of V, approaching 
a 2 A 
infinity are shown along the right side of Figure 21. Note from Figure 
22 that abnormally high values of shunting do not appreciably increase the 
time required to rid the tissues of excess carbon dioxide. It can be con­
cluded that relatively little is gained by increasing alveolar ventilation 
beyond a value corresponding to V^/M = 50. 
Pulmonary shunting also affects the degree of arterial blood oxygen 
saturation. Increased alveolar ventilation induced by respiratory augmen­
tation will help to increase the p^Og only if the additional inspired gas 
participates in gaseous exchange with otherwise unsaturated blood. In­
spired gas oxygen concentration is the predominant factor in determining 
the p 0 level. Figure 23 shows the p 0„ expected for various values of 
• a 2 a 2 
shunting and inspired oxygen concentrations. The data presented is ob­
tained from numerical evaluation of equation 4-18. When venous admixture 
exceeds a value of approximately 30 per cent, complete oxygen saturation of 
the arterial blood cannot be attained with 100 per cent oxygen at normal 
barometric pressure. With shunting of 60 per cent of the blood around the 
active lung alveoli (k = 0.6) the arterial blood will be 73 per cent satu­
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rated if pure oxygen is inhaled. When shunting becomes severe, such-as 
k = 0.6, increased oxygen concentrations are ineffective in raising p^Og. 
This explains the clinical observation that very severely distressed in­
fants (k = 0.6 approximately) fail to respond to increased oxygen concen­
trations and their cyanotic condition remains unimproved. Less severely 
distressed infants (k = 0.4 approximately) respond noticeably to increased 
oxygen concentrations. 
Increasing the physically dissolved oxygen in the blood by means of 
hyperbaric oxygenation produces, with 60 per cent shunting, a p^Og of 55 mm 
Hg at two atmospheres pressure. At three atmospheres of pure oxygen the 
Pg02 is raised to 166 mm Hg. In the case of hyperbaric oxygenation, equa­
tion 4-18 becomes 
X = .216 + .0235 (N - 1)(1 - k) - .256 K (4-28) 
'a 1 - k 
where 
N = number of atmospheres pressure, absolute 
Concentrations are converted to partial pressures using the neonatal 
blood oxygen dissociation curves of Edwards and Ross (33) for an assumed 
arterial CO2 tension of 50 mm Hg. The only significant error in Figure 23, 
if present, is the assumption of no resistance to diffusion of oxygen 
across the alveolar-capillary membrane. With this assumption in mind. 
Figure 23 can be used for the quantitative evaluation of effective circula­
tory shunting. 
Pressure Waveform Interpretation 
Assessment of the mechanical condition of the lungs is also important 
in the clinical application of a respirator or augmenter. Pressures 
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developed in the thorax and at the nose by devices used to assist respira­
tion are a function of the resistance, inertial component, and compliance 
of the thorax and total pulmonary system respectively. The monitoring of 
nasal and pleural pressure waveforms is a relatively simple method of 
qualitatively evaluating changes in the pathologic condition of the infant 
and also the relative effectiveness of the respiratory augmentation. Di­
minished lung compliance, for example, signifies increased severity of 
respiratory distress. Improper matching of the augmenter to the infant as 
indicated by abnormal pressures is another example of the usefulness of. 
pressure monitoring. 
A theoretical study of the significance of the various waveshapes 
encountered clinically was undertaken. An infinite variety of nasal and 
intrathoracic pressure waveforms are possible. Variations of the basic 
waveforms can be caused by changes in augmenter output volume or flow rate 
or change in the infant's lung compliance, etc. Hence, a number of wave­
forms seen previously in clinical and laboratory applications of the aug­
menter were chosen as representative and an effort made to simulate them. 
An electrical analog of the pulmonary system as described in Chapter 2 was 
used as the simulator. 
An electrical circuit, essentially the same as Figure 2, served as an 
analog of the pulmonary mechanics and was used to generate voltage wave­
forms similar to the pressure waveforms produced by respiratory augmentation. 
A pulsed constant current power source connected to the terminals repre­
senting the nose simulated a constant flow respirator, while a low imped­
ance exponential waveform voltage generator simulated the pressures pro­
duced by the respiratory muscles. A complete schematic diagram of the 
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simulator is shown in Figure 3. The generators were operated synchronously 
by a timing circuit to simulate augmented respiration. 
The lungs were simulated by three parallel combinations of a resistor 
and capacitor in series. This circuit simulated a congested lung, producing 
air trapping. in Figure 3 represents the expiratory resistance caused by 
minor flow resistances in the augmenter, particularly the resistance of the 
one-way valve through which expired air flows. represents the combined 
compliance of the nasopharyngeal region of the infant and the tubing con­
necting the augmenter to the infant. Other components of the analog are as 
described previously in Chapter 2. In the analog, 1.0 microfarad represents 
a compliance of 1.0 ml per cm HgO, and 1.0 megohm of resistance equals a 
flow resistance of 1.0 cm HgO per ml per second. 
Figures 25 through 31 show the simulated pressure waveforms produced by 
the analog. These figures were recorded using a curvilinear type recorder. 
Thus some distortion is present occurring as a slight bowing to the left. 
The simulator timing circuit produced an inspiratory phase of 0.3 seconds 
and an expiratory phase of 0.7 seconds. The expiratory phase was pur­
posely exaggerated to enhance the separation between phases. The pleural 
pressure produced by the respiratory muscles was simulated with the same 
wave shape as used in the optimization analysis, i.e., 
Ppj = - pQ (1 - e -at) (4-29) 
The inspiratory duration lasted approximately two time constants. While it 
is the pleural pressure that is observed to be exponential, the muscle 
source is assumed exponential for simplification. It would more accurately 
be a sum of exponentials. However, the resulting error is small. 
A large number of waveforms representing the various types of dys­
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function have been simulated. The more interesting and pertinent waveforms 
are shown in Figures 25 through 31. Many of these will be recognized as 
the same wave shapes as shown in other figures in this dissertation. 
Pleural, intrapulmonary, and nasal pressures are shown, as well as the mus­
cle source. The intrapulmonary and muscle pressures are shotcn for refer­
ence and are not observable experimentally. 
Figure 25 shows the waveforms produced by constant air flow into a 
passive pulmonary system. It is presented to indicate the augmenter's con­
tribution to the pressure waveform. Figures 26, 27, and 28 show the pres­
sures observed when the augmenter characteristics are improperly matched 
to the infant. An indication of mismatch is most apparent in the pleural 
pressure waveform. The optimal tidal volume and flow rate from the aug­
menter produce an intrathoracic waveform as shown in Figure 29. 
Figure 30 shows the results of a compliance increase of 25 per cent in 
the simulated lung section having least congestion. Notice the difference 
in the negative peaks of the pleural pressure between this figure and the 
preceding one. Figure 31 illustrates the opposite situation, that of 
stiff, congested lungs. This condition is simulated in the analog by two 
parallel branches of a series combination of 1.0 microfarad and lOOK ohms, 
equivalent to a compliance of 1 ml per cm H2O and a congestive flow re­
sistance of 0.1 cm H2O per ml per second. 
Summary 
The prognosis for the severely distressed infant is poor if pulmonary 
shunting exceeds 60 per cent, as shown by the data of Figures 18, 19, 21, 
and 22. The prognosis is good, however, if pulmonary shunting remains 
less than 40 per cent, assuming that adequate alveolar ventilation can be 
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maintained. 
Abnormally high blood carbon dioxide tensions are shown to be caused, 
at least in part, by normal functioning of the respiratory control system. 
Large values of pulmonary shunting and dead space reduce the system's 
sensitivity and thus produce a large operating error in the system. An 
arbitrary measure of the effector portion of the system's sensitivity is 
shown in Figure 19. Data is presented in Figures 21 and 22 to show the 
potential effect of increased alveolar ventilation on the excessive carbon 
dioxide tension for the hypothetical infant. Figure 23 shows the concen­
tration of inspired oxygen necessary to achieve oxygenation of the arter­
ial blood when shunting is present. Severe shunting is sho\m to prevent 
normal PqQ2 levels even when pure oxygen is inhaled. Finally, the effect 
of pulmonary dysfunction on pulmonary pressure waveforms seen clinically 
is discussed. Pleural and nasal pressure waveforms generated by the 
action of a constant flow respiratory augmenter provide a good qualitative 
index of the sufficiency of augmented respiration. 
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SUKuWY OF CLINICAL RESULTS 
An indisputable conclusion regarding the efficacy of respiratory aug- . 
mentation for specific therapy in the treatment of respiratory distress is 
impossible at this time. Controlled experiments matching treated infants 
and similarly distressed untreated infants are not feasible,. Only a long 
term statistical study can reveal the adequacy of respiratory augmentation 
therapy for distressed infants. With these limitations in mind, the clini­
cal "success" of the respiratory augmentation process described in this 
study will be reviewed. 
The respiratory augmenter was first tested on urethane anesthetized 
rabbits, the attachment to the augmenter being by means of tracheotomy (38). 
•V 
Rabbits were used to simulate newborn infants during the development of the 
equipment and associated theory. A few rabbits were subjected to respira­
tory augmentation for 43 hours. None showed any evidence of lung damage 
at necropsy. 
The first clinical trial of the augmenter involved a week old three 
pound premature infant who had developed recurring periods of apnea 48 
hours previous to the start of respiratory augmentation. During the four 
hour period prior to the application of the augmenter, periods of apnea in 
excess of 8 minutes occurred at about half hour intervals. The infant 
appeared cyanotic and his muscle tone was nearly absent. It was evident 
to the attending pediatricians that death was imminent. The infant's color 
improved markedly shortly after being connected to the augmenter, and his 
muscle tone soon returned. No further apnea occurred; therefore, respira­
tory augmentation was stopped after 12 hours. Subsequently, the apnea 
returned. Augmentation was resumed, but death occurred 48 hours later. 
From clinical evaluation, it was felt that death was due to a central 
nervous system malfunction incurred during the anoxic intervals existing 
before the augmenter was applied^. No blood gas measurements were obtained 
during this trial. 
Another application of the augmenter was in conjunction with the 
treatment of a four pound premature infant. Within 12 hours after birth, 
this infant's respiratory rate had risen to 72 breaths per minute. An X-ray 
examination made shortly thereafter showed severe bilateral hyaline membrane 
disease. Respiratory augmentation was instituted when the infant was 20 
hours of age. Blood gas data obtained.concurrently indicated a p CO^ of 
40 mm Hg and a p 0 of 19 mm Hg. (The infant was inhaling a 40 oer cent 
oxygen concentration at the time.) The severe shunting indicated by the 
very low p^Og is shown in Figure 23 to be in excess of 60 per cent. Acetyl­
choline (administered iv.) was employed to lessen the apparent vasospasm, 
and thus to reduce shunting, '.'ith the augmenter delivering a minute vol­
ume, V^, of approximately 2200 ml per minute, the infant's pCOg level was 
maintained continuously at a level of 30 to 35 mm Hg. Respiratory augmen­
tation was continued for approximately 80 hours, after which the infant 
recovered uneventfully. 
Although many of the infants treated are now alive and healthy, it 
cannot be said with certainty that survival was directly attributable to 
respiratory augmentation. Further research should help to clarify this 
point. It is certain, however, that the augmenter helps to reduce the 
infant's respiratory effort and also promotes the elimination of excess 
^McCormack, w. C., McFarland Clinic, Ames, Iowa, Clinical records. 
Private communications. 1963. 
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carbon dioxide. 
When the distressed infants were placed on the augmenter, a marked 
improvement in color and a decrease in apparent respiratory effort were 
almost always observed. The infants soon went to sleep. To rule out coin­
cidental improvement, in most cases the respiratory augmenter has been 
removed briefly and the infant placed in an incubator. With an identical 
oxygen concentration maintained in the incubator as that delivered by the 
augmenter, the infant reverted to labored respiration, as evidenced by 
increased thoracic wall retraction. The infant's skin color soon became 
darker, indicating a decrease in blood oxygen saturation. 
A method for measuring the relative contributions of the augmenter 
and the infant to the total respiratory effort has not yet been devised 
(39). If the patient's pleural pressure is positive (relative to that at 
the end of expiratory pause) during the inspiratory phase when respiration 
is augmented, the augmenter must be contributing to the total respiratory 
effort. After the brief interval following connection to the augmenter, 
during which adaptation occurs, positive going pleural pressures have been 
observed in practically all infants and laboratory animals. Figure 32 
shows the nasal and intraesophageal (intraesophageal and pleural pressures 
being equivalent) pressures measured in a distressed infant connected to 
the augmenter. Note the negative going pressure produced by an attempt to 
sigh. 
The respiratory augmenter has been used in the treatment of 16 in­
fants to date and appears to be successful in.fulfilling its intended 
purpose. 
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Table 1. Cardiopulmonary parameters of newborn infant® 
Parameter Healthy infant 
Distressed 
infant^ 
Respiratory rate 35 b/min 70 b/min 
Lung compliance, 5 ml/cm H 0 
2 
2 ml/cm HgO 
Thorax compliance, Cj. 5 ml/cm H^O 
Airway resistance, 30 cm HgO/l/sec 
Hass of gas in airway, .013 cm HgO/l/sec^ 
Tidal volume, 12 ml 10 ml 
Dead space, 4 ml 6 ml 
Cardiac output, Q .30 1/min 
Metabolic output, M .012 1/min 
Equivalent tissue volume, 2.0 1 
Lung volume (F.R.C.), 80 ml 45 ml 
^Average for 2.5 kg premature infant. 
^Where not given, values are either the same as for healthy infants 
or unknown. 
